NCT05115045已完成不适用
Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients (pRNA-COVID-ICU)
Hopital of Melun1 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2021年11月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 122
- 试验地点
- 1
- 主要终点
- Day 60 mortality
研究概览
简要总结
Retrospective, observationnal study. Evaluation of the association between plasmatic SARS-CoV-2 RNA and day 60 mortality in ICU adult COVID-19 patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age above 18 years
- •in ICU hospitalization
- •COVID-19 related pneumonia confirmed by PCR
排除标准
- •plasmatic SARS-COV-2 RNA quantification not available
- •patient's refusal to participate
结局指标
主要结局
Day 60 mortality
时间窗: 60 days
Association between plasmatic SARS-CoV-2 RNA level and mortality
次要结局
未报告次要终点
研究者
Sebastien Jochmans, MD
Head of Clinical Research Unit
Hopital of Melun
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Noncoding RNAs in COVID-19 and COVID-19 Related Kidney DysfunctionCOVID-19NCT04381351Heinrich-Heine University, Duesseldorf50
已完成
不适用
Diagnostic and Prognostic Biomarkers in SARS-CoV-2 InfectionsIBD - Inflammatory Bowel DiseaseCOVID - 19NCT06774638IRCCS Azienda Ospedaliero-Universitaria di Bologna36
Unknown
不适用
A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 DiseaseCOVIDConjunctivitisNCT04346160G. d'Annunzio University25
已完成
不适用
Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab ApplicationCOVID-19Outcome, FatalTocilizumabInterleukin 6Critically IllNCT06233357University of Ulm95
Unknown
2 期
Convalescent Plasma Transfusion in Severe COVID-19 Patients in JamaicaCOVID-19, Convalescent Plasma TreatmentNCT04644198The University of The West Indies30